AmyloiDia Sweden AB
559216-2332ActiveDeveloping single-molecule sensitive blood tests for pre-symptomatic Alzheimer's diagnosis.
Biotechnology Companyamyloidia.se
Yleiskatsaus
- 0
- Työntekijät
- 100–149t SEK
- Liikevaihto
- 2019
- Perustettu
Avainpäättäjät
Dr Vladana Vukojević
CEO and Co-founder
@amyloidia.se+46703XXXXXX
Ann Tiiman
Co-founder and Researcher
@amyloidia.se+46767XXXXXX
Sebastian Wärmländer
Steering Board Member and Co-founder
@amyloidia.se
Astrid Gräslund
Steering Board Chair and Co-founder
@amyloidia.se
+15 lisää yhteystietoja Funnelfeedrissä
Kuvaus
AmyloiDia is an R&D-driven BioMedTech company dedicated to eradicating Alzheimer’s disease through early diagnosis. Their core mission involves translating advanced quantitative analytical methods into clinical healthcare applications. They have invented a novel, minimally invasive blood-based techn...
PRE DIAGNOSTICS AS